Abstract
The objective of our study was to evaluate the knowledge of alcohol as a risk factor for liver disease among patients with chronic hepatitis C who have achieved a sustainable viral response (SVR) after receiving direct antiviral medication (DAA). Methods: The study cohort included patients from the Hepatitis C Elimination Program treated with direct antiviral drugs (DAA) in Tbilisi (Georgia). A total of 210 patients were studied. Data were processed in the statistical program SPSS26.The Student's t-test was used. P-value less than 0.05 was considered statistically significant. Results: The study was conducted in 2021.These data were collected before and during treatment.The majority had used alcohol during their lifetime.12.5% of males think that taking more than 10 glasses of alcohol is normal for health.Older age and higher education were positively associated with respondents' awareness regarding outcomes of heavy alcohol drinking (p < 0.01)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
